Browsing by Author "Pectasides, D."
Now showing items 1-5 of 5
-
Accelerated hypofractionated radiotherapy schedules in breast cancer: A review of the current literature
Kalogeridi, M. A.; Kelekis, N.; Kouvaris, J.; Platoni, K.; Kyrias, G.; Pectasides, D.; Kouloulias, V. (2009)Lumpectomy followed by breast irradiation is an alternative to mastectomy for patients with early-stage breast cancer. The purpose of radiation treatment following lumpectomy is to minimize the risk of recurrent cancer in ... -
Association of VEGF-A Splice Variant mRNA Expression With Outcome in Bevacizumab-Treated Patients With Metastatic Breast Cancer
Pentheroudakis, G.; Kotoula, V.; Kouvatseas, G.; Charalambous, E.; Dionysopoulos, D.; Zagouri, F.; Koutras, A.; Papazisis, K.; Pectasides, D.; Samantas, E.; Dimopoulos, M. A.; Papandreou, C. N.; Fountzilas, G. (2014)We studied tissue mRNA levels of VEGF-Axxxa angiogenic versus VEGF-Axxxb anti-angiogenic isoforms by means of specially designed PCR assays in two parallel cohorts of metastatic breast cancer patients, one treated with ... -
Docetaxel and Intermittent Erlotinib in Patients with Metastatic Non-small Cell Lung Cancer; A Phase II Study From The Hellenic Cooperative Oncology Group
Karavasilis, V.; Kosmidis, P.; Syrigos, K. N.; Mavropoulou, P.; Dimopoulos, M. A.; Kotoula, V.; Pectasides, D.; Boukovinas, I.; Klouvas, G.; Kalogera-Fountzila, A.; Papandreou, C. N.; Fountzilas, G.; Briasoulis, E. (2014)Aim: To determine the more effective dosing sequence of intermittent erlotinib and docetaxel for treating chemotherapy-naive patients with advanced Non-Small Cell Lung Cancer (NSCLC). Patients and Methods: Patients were ... -
Dose-dense sequential adjuvant chemotherapy followed, as indicated, by trastuzumab for one year in patients with early breast cancer: first report at 5-year median follow-up of a Hellenic Cooperative Oncology Group randomized phase III trial
Fountzilas, G.; Dafni, U.; Papadimitriou, C.; Timotheadou, E.; Gogas, H.; Eleftheraki, A. G.; Xanthakis, I.; Christodoulou, C.; Koutras, A.; Papandreou, C. N.; Papakostas, P.; Miliaras, S.; Markopoulos, C.; Dimitrakakis, C.; Korantzopoulos, P.; Karanikiotis, C.; Bafaloukos, D.; Kosmidis, P.; Samantas, E.; Varthalitis, I.; Pavlidis, N.; Pectasides, D.; Dimopoulos, M. A. (2014)Background: Dose-dense sequential chemotherapy including anthracyclines and taxanes has been established in the adjuvant setting of high-risk operable breast cancer. However, the preferable taxane and optimal schedule of ... -
Post-operative combined radiation and chemotherapy with temozolomide and irinotecan in patients with high-grade astrocytic tumors. A phase II study with biomarker evaluation
Fountzilas, G.; Karkavelas, G.; Kalogera-Fountzila, A.; Karina, M.; Ignatiadis, M.; Koukoulis, G.; Plataniotis, G.; Misailidou, D.; Bobos, M.; Pectasides, D.; Razis, E.; Karavelis, A.; Selviaridis, P. (2006)Background: Clinical studies have shown that temozolomide (TMZ) and irinotecan demonstrate activity in high grade astrocytic tumors (HGAT). However, the optimal schedule of administration is unknown. Patients and Methods: ...